Abbott Stops Marketing Weight Loss Drug In Europe
Abbott Laboratories on Thursday suspended the marketing of its weight loss drug in Europe after a European agency indicated the drug increases the risk of heart attack and stroke in patients...To view the full article, register now.
Already a subscriber? Click here to view full article